Literature DB >> 6450527

Intracoronary thrombolysis in evolving myocardial infarction.

W Ganz, N Buchbinder, H Marcus, A Mondkar, J Maddahi, Y Charuzi, L O'Connor, W Shell, M C Fishbein, R Kass, A Miyamoto, H J Swan.   

Abstract

After experimental studies in dogs confirmed the feasibility and safety of rapid intracoronary thrombolysis by local infusion of Thrombolysin (streptokinase and plasmin), intracoronary thrombolysis was attempted in 20 patients with evolving myocardial infarction who were hospitalized within 3 hours from the onset of symptoms during the day and within 2 hours at night. Thrombolysin was infused in the immediate vicinity of the site of coronary occlusion using a 0.85 mm outer diameter catheter advanced through the lumen of the Judkins catheter. Reperfusion was achieved in four patients after an average of 43 minutes of Thrombolysin infusion at a rate of 2000 IU/min and in 15 patients after an average of 21 minutes of Thrombolysin infusion at a rate of 4000 IU/min. The failure to open the artery in one patient may have been caused by our inability to advance the infusion catheter close to the site of occlusion. Rethrombosis occurred in one patient 8 days after reperfusion and 2 days after discontinuation of anticoagulants because of a history of chronic alcoholism. Wall motion and perfusion studies showed improvement following reperfusion. Patency of the artery was achieved an average of 4 hours after the onset of symptoms. The need for earlier reperfusion is emphasized.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450527     DOI: 10.1016/0002-8703(81)90376-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  34 in total

Review 1.  Advances in the medical management of acute coronary syndromes.

Authors:  C P Cannon
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Time to Reperfusion: The Critical Modulator in Thrombolysis and Primary Angioplasty.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Pathobiology of Myocardial Necrosis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 4.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi; Y Birnbaum
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

5.  Coronary artery bypass in perspective.

Authors:  R J Hall
Journal:  Tex Heart Inst J       Date:  1989

6.  Streptokinase thrombolysis in acute myocardial infarction: a turning point.

Authors:  P Angelini; R Leachman
Journal:  Tex Heart Inst J       Date:  1983-12

7.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

8.  Internal medicine-important advances in clinical medicine: streptokinase and acute myocardial infarction.

Authors:  W Ganz
Journal:  West J Med       Date:  1983-05

9.  Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.

Authors:  J Owen; K D Friedman; B A Grossman; C Wilkins; A D Berke; E R Powers
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

10.  [Arrhythmia as an indicator for reperfusion following acute myocardial infarct?].

Authors:  K Langes; W Bleifeld; D G Mathey; K H Kuck
Journal:  Klin Wochenschr       Date:  1989-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.